Healthy Adult Males Volunteers

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

S
SantenCA - Emeryville
1 program
1
STN1012600 ophthalmic solution 0.002%Phase 11 trial
Active Trials
NCT05905653Completed8Est. Jun 2023

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
SantenSTN1012600 ophthalmic solution 0.002%

Clinical Trials (1)

Total enrollment: 8 patients across 1 trials

NCT05905653SantenSTN1012600 ophthalmic solution 0.002%

Pharmacokinetic Study of STN1012600 Ophthalmic Solution in Healthy Adult Males Volunteers

Start: May 2023Est. completion: Jun 20238 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space